BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10531318)

  • 1. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
    Nagarajan RP; Liu J; Chen Y
    J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of FAST-1 and Smads in transcriptional regulation by activin during early Xenopus embryogenesis.
    Yeo CY; Chen X; Whitman M
    J Biol Chem; 1999 Sep; 274(37):26584-90. PubMed ID: 10473623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
    Liu F; Pouponnot C; Massagué J
    Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
    Nagarajan RP; Zhang J; Li W; Chen Y
    J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
    Pierreux CE; Nicolás FJ; Hill CS
    Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4 and FAST-1 in the assembly of activin-responsive factor.
    Chen X; Weisberg E; Fridmacher V; Watanabe M; Naco G; Whitman M
    Nature; 1997 Sep; 389(6646):85-9. PubMed ID: 9288972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
    Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
    EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
    Kuang C; Chen Y
    Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
    Stroschein SL; Wang W; Luo K
    J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
    Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
    Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
    Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
    J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.
    Labbé E; Silvestri C; Hoodless PA; Wrana JL; Attisano L
    Mol Cell; 1998 Jul; 2(1):109-20. PubMed ID: 9702197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.
    Nagarajan RP; Chen Y
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):253-9. PubMed ID: 10926851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.
    Germain S; Howell M; Esslemont GM; Hill CS
    Genes Dev; 2000 Feb; 14(4):435-51. PubMed ID: 10691736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.